Drug Test for Qualitative Analysis of Cells Expressing HLA-DR Antigen - Vietnam Registration 2401177ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Drug Test for Qualitative Analysis of Cells Expressing HLA-DR Antigen in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2401177ĐKLH/BYT-HTTB and manufactured by Immunotech SAS. The authorized representative in Vietnam is CÔNG TY TNHH KỸ THUẬT NAM PHƯƠNG.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2401177ĐKLH/BYT-HTTB
000.00.04.G18-211129-0023
Anti-HLA-DR-Pacific Blue
B36291
Technical Details
Anti-HLA-DR-Pacific Blue, a combined antibody with fluorescent dye, enables the qualitative and quantitative determination of cell populations expressing the HLA-DR antigen in human biological samples using flow cytometry.
Dates and Status
Jul 22, 2024

